Published in Int J Mol Sci on July 08, 2015
HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis. J Cancer (2016) 0.87
lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma. Oncol Lett (2017) 0.75
Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach. Int J Mol Med (2017) 0.75
RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2. Onco Targets Ther (2017) 0.75
Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Oncotarget (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics (2002) 30.58
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol (1999) 21.92
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics (2004) 19.05
Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58
Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem (1988) 9.56
Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci U S A (1996) 8.10
Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis (1997) 5.06
Cytokines and the hepatic acute phase response. J Pathol (1997) 2.94
Morphological classification of plant cell deaths. Cell Death Differ (2011) 2.28
Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res (2006) 1.94
Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med (1990) 1.88
Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics (2004) 1.82
Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J (2006) 1.80
Nasopharyngeal carcinomas: an update. Eur J Cancer (2003) 1.78
A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry. J Thromb Haemost (2006) 1.71
Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem (2008) 1.67
Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene (2006) 1.66
Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer (2007) 1.61
Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene (2005) 1.60
Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics (2010) 1.52
P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol (1993) 1.51
MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle (2012) 1.50
An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (1978) 1.48
Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol (2010) 1.48
Imaging mass spectrometry: fundamentals and applications to drug discovery. Drug Discov Today (2005) 1.47
Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res (2010) 1.46
Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis (1995) 1.41
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res (2008) 1.38
Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci (2006) 1.36
Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. Cancer Res (2008) 1.34
Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res (2008) 1.33
Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics (2005) 1.32
Pattern recognition in gene expression profiling using DNA array: a comparative study of different statistical methods applied to cancer classification. Hum Mol Genet (2003) 1.29
Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era. Radiother Oncol (2014) 1.28
Methods for fractionation, separation and profiling of proteins and peptides. Electrophoresis (2002) 1.22
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev (2009) 1.19
MALDI imaging mass spectrometry: statistical data analysis and current computational challenges. BMC Bioinformatics (2012) 1.18
Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin Cancer Res (2003) 1.16
Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res (2003) 1.14
MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur J Cancer (2013) 1.14
EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Stem Cell Reports (2015) 1.13
Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism. Int J Cancer (2010) 1.11
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma. Mol Ther (2013) 1.10
Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Hepatology (2006) 1.10
MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res (2007) 1.08
Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. J Pathol (2008) 1.08
Basics and recent advances of two dimensional- polyacrylamide gel electrophoresis. Clin Proteomics (2014) 1.07
A novel proteomic approach for specific identification of tyrosine kinase substrates using [13C]tyrosine. J Biol Chem (2004) 1.05
Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol (2009) 1.05
Noninvasive imaging of protein metabolic labeling in single human cells using stable isotopes and Raman microscopy. Anal Chem (2008) 1.03
Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. J Histochem Cytochem (2010) 1.02
Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res (2008) 1.01
Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics (2006) 1.01
Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest (2013) 1.01
Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway. J Hematol Oncol (2015) 1.01
Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma. Clin Exp Metastasis (2012) 1.00
IL-8 and cathepsin B as melanoma serum biomarkers. Int J Mol Sci (2011) 1.00
Increased importin-beta-dependent nuclear import of the actin modulating protein CapG promotes cell invasion. J Cell Sci (2004) 0.99
Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis. Proteomics (2010) 0.99
Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells. In Vivo (2005) 0.99
Two-dimensional gel electrophoresis for proteome projects: the effects of protein hydrophobicity and copy number. Electrophoresis (1998) 0.98
Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Int J Oncol (2012) 0.98
The Goodwin model: behind the Hill function. PLoS One (2013) 0.97
Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J Med Invest (2006) 0.97
Highly resolving two-dimensional gels for protein sequencing. Proc Natl Acad Sci U S A (1991) 0.95
Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma. J Proteome Res (2006) 0.94
Low-dose radiation-induced epithelial-mesenchymal transition through NF-κB in cervical cancer cells. Int J Oncol (2013) 0.94
PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1. EMBO J (2006) 0.92
An imageable metastatic treatment model of nasopharyngeal carcinoma. Clin Cancer Res (2007) 0.92
Prohibitin attenuates colitis-associated tumorigenesis in mice by modulating p53 and STAT3 apoptotic responses. Cancer Res (2012) 0.92
Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics (1992) 0.92
Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. J Proteome Res (2008) 0.92
Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma. Int J Cancer (2013) 0.92
The progress on genetic analysis of nasopharyngeal carcinoma. Comp Funct Genomics (2007) 0.91
Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. Int J Cancer (2014) 0.90
Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Cancer (2008) 0.90
Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics. J Proteomics (2010) 0.90
Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads. J Cell Biochem (2012) 0.90
Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma. J Proteome Res (2009) 0.89
Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma. Arch Pathol Lab Med (2008) 0.89
Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3. J Proteome Res (2013) 0.89
Clinical analysis of 1,000 cases of nasopharyngeal carcinoma with particular reference to early diagnosis and clinical types of late cases. Chin Med J (1965) 0.89
Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Int J Clin Oncol (2012) 0.89
Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS. Exp Oncol (2006) 0.88
Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue. J Cell Biochem (2009) 0.87
Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Int J Oncol (2011) 0.87
Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human. Proteomics (2004) 0.87
Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis. Oncol Rep (2010) 0.87
Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer. Oncol Rep (2013) 0.86
Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics. Proteome Sci (2011) 0.86
HSP70 and mucin 5B: novel protein targets of N,N'-dinitrosopiperazine-induced nasopharyngeal tumorigenesis. Cancer Sci (2009) 0.85
Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics. J Proteome Res (2010) 0.85
The application of SELDI-TOF-MS in clinical diagnosis of cancers. J Biomed Biotechnol (2011) 0.85
cAMP signaling inhibits radiation-induced ATM phosphorylation leading to the augmentation of apoptosis in human lung cancer cells. Mol Cancer (2014) 0.85
QSOX1 inhibits autophagic flux in breast cancer cells. PLoS One (2014) 0.85
Matrix-assisted laser desorption mass spectrometry of rhodopsin and bacteriorhodopsin. Biophys J (1992) 0.85